ALC alcon.com Net earnings per share growth forecast for next year

Corporate company logo of Alcon Inc (ALC)

Alcon Inc. leads the ophthalmology sector, benefiting from the global aging population. The shift in analyst EPS growth estimates visualizes this trend, where the 12.60 level represents the current value. Market capitalization is based on the sale of microsurgical equipment and vision care products. Business efficiency is supported by a network of automated hubs that guarantee strict compliance with international delivery standards.

ALC: Alcon Vision Expected earnings per share growth for next year 07/04/2022 - 11/11/2026

Analytical breakdowns for alcon.com (ALC)

- share price and consensus valuation forecast:
Stock Price Alcon Vision|ALC - Analyst Consensus Forecast
- market capitalization data:
Market Value Alcon|ALC - Total Company Value
- company book value details:
Book Value per Share Alcon|ALC - Company Net Assets|Market Value to Book Value Ratio alcon.com|ALC - Company Assets
- debt and solvency information:
Debt to Equity Alcon Inc.|ALC - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Ratio Alcon|ALC - Aggregate Debt Obligations|Debts to Book Capitalization Alcon|ALC - Long-Term Debt Volume|Company Short-Term Debt Alcon|Quick Ratio alcon.com
- earnings and valuation multiples information:
ALC - Net Income|Future Profit Alcon Inc.|ALC - Business Payback Period|Forward P/E Multiple Alcon Inc.|ALC - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Alcon|ALC - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Alcon|ALC - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months alcon.com|ALC - Earnings per share trend in current year|Earnings growth forecast for next year Alcon Inc.
Fundamental company valuation:Alcon Vision, ALC
Core merchandise of Alcon Inc

This indicator measures the expected earnings per share (EPS) dynamics, reflecting the analysts' consensus forecast for future capital efficiency. Next-year EPS forecast trends for Alcon Inc. (ALC) on the GURU.Markets platform visualize the real-time shift in market expectations. The calculation is based on the aggregation of projected net income, adjusted for the number of shares outstanding. For Alcon Inc. (ALC), this metric confirms business resilience driven by its dominance in the ophthalmology equipment and consumables niche.

Competitor analysis

BLCO (Bausch + Lomb Corp) - Earnings growth forecast for next year|Earnings growth forecast for next year Glaukos Medical|Net earnings per share growth forecast for next year Apellis Pharmaceuticals (APLS)|Net earnings per share growth forecast for next year BLTE (Belite Bio, Inc.)|Earnings growth forecast for next year OCUL (Ocular Therapeutix, Inc.)|HROW - Expected earnings per share growth for next year|VRDN - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year LENZ Corp|oculis.com (OCS) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year EYPT|Expected earnings per share growth for next year KOD|ALDX: Expected earnings per share trend next year|Earnings growth forecast for next year KALA|Consensus forecast of earnings per share growth for next year opusgtx.com|Net earnings per share growth forecast for next year OKYO Pharma OKYO|ADVM: Projected earnings per share growth rate for next year|Outlook Therapeutics, Inc. - Earnings growth forecast for next year|Clearside Biomedical Inc (CLSD) - Expected earnings per share growth for next year|NBY (novabay.com) - Expected earnings per share growth for next year|KPRX - Consensus forecast of earnings per share growth for next year|ALIM (Alimera Sciences Inc) - Earnings growth forecast for next year|Earnings growth forecast for next year Eyenovia Corp|Net earnings per share growth forecast for next year Guardion Health Sciences (GHSI)|Net earnings per share growth forecast for next year OCUP (Ocuphire Pharma Inc)|Earnings growth forecast for next year OPT (Opthea Ltd.)